English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Myeloproliferative neoplasms (MPN) are clonal hematopoietic disorders characterized by proliferation and hyperplasia of maturing myeloid cells in bone marrow (BM). Characteristic genetic alterations are found in the majority of MPN patients, including BCR-ABL1 fusion in all chronic myelogeneous

IDH1 R132H mutation is a rare event in myeloproliferative neoplasms as determined by a mutation specific antibody